瑞法奈珠单抗

瑞法奈珠单抗INN:Refanezumab;开发代号:GSK249320)是一种单克隆抗体,设计用于中风后运动功能的恢复。[1][2]该药物由葛兰素史克公司开发。

瑞法奈珠单抗
单克隆抗体
种类?
目标髓磷脂相关糖蛋白英语Myelin-associated glycoprotein
临床资料
其他名称GSK249320
ATC码
  • 未分配
识别信息
CAS号1233953-61-1
ChemSpider
  • none
UNII
化学信息
化学式C6608H10156N1732O2064S44
摩尔质量148,298.64 g·mol−1

参考资料

  1. ^ Refanezumab (PDF). Statement On A Nonproprietary Name Adopted By The USAN Council. American Medical Association. .
  2. ^ Cramer SC, Enney LA, Russell CK, Simeoni M, Thompson TR. Proof-of-Concept Randomized Trial of the Monoclonal Antibody GSK249320 Versus Placebo in Stroke Patients. Stroke. March 2017, 48 (3): 692–698. PMC 5325241 . PMID 28228578. doi:10.1161/STROKEAHA.116.014517.